2022-10-21

ROI-NJ: BD’s new Onclarity HPV test greatly improves standard of care for women

ROI-NJ: BD’s new Onclarity HPV test greatly improves standard of care for women

Molly Broache, Associate Director, Medical Affairs for US IDS explains how the BD Onclarity™ HPV Assay positively impacts public health by providing a more precise estimate of a woman’s risk of cervical precancer and cancer.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Business Insider
Cervical Cancer | News & Updates
Business Insider: Getting the HPV vaccine and regular testing can help protect you from high-risk HPV strains that cause cancer
New study shows substandard approaches to diagnosis and treatment for vaginal discharge syndromes
Vaginitis | News & Updates
Press release: New study shows substandard approaches to diagnosis and treatment for vaginal discharge syndromes
BD Onclarity™ HPV Assay with extended genotyping
Cervical Cancer | Brochures
BD Onclarity™ HPV Assay with extended genotyping